Retatrutide comes up more than any other compound in the questions we get in Egypt. This is an overview of what published work actually describes, and how it differs from the compounds most people have already heard of.
A triple agonist, and why that phrase matters
Retatrutide is a synthetic 39-amino-acid peptide from the glucagon peptide family. What separates it in the literature is that it binds three receptors rather than one or two: GLP-1, GIP and glucagon.
To put that in order:
- Single agonist — acts on GLP-1 alone. Semaglutide, the compound behind Ozempic and Wegovy, sits here.
- Dual agonist — adds GIP. Tirzepatide, behind Mounjaro, sits here.
- Triple agonist — adds glucagon on top. Retatrutide sits here.
The first two receptors are associated in published work with appetite signalling and glucose regulation. The glucagon receptor is the addition, and it is the one linked to energy expenditure rather than intake alone. So where a single or dual agonist is described mainly in terms of how much someone eats, the triple mechanism is discussed as acting on both sides of the equation.
What trials report
- Activity across all three receptor pathways rather than appetite signalling alone
- Effects on satiety pathways and on metabolic rate under trial conditions
- Gastrointestinal discomfort and fatigue among the most frequently reported adverse events
- Those effects reported most often during early dose escalation rather than later
An honest word on where it stands
Retatrutide is newer than the compounds it gets compared to, and the body of published work behind it is correspondingly smaller. Anyone telling you it is simply a stronger version of something familiar is skipping that. The mechanism is genuinely different; the depth of evidence is not yet the same. Both things are true.
It is also worth saying plainly that this is not a decision to make from a product page. Speak to a doctor, particularly if you have any history of blood sugar, thyroid or gastrointestinal conditions.
Storage is not a footnote
This matters more in Egypt than most places. Retatrutide is heat-sensitive and Cairo summers pass 40°C routinely. A vial that is entirely genuine can still arrive degraded if it spent weeks in an unrefrigerated warehouse or the back of a van.
When comparing suppliers, the question worth asking is not only where the product came from, but how it travelled. Refrigerated air freight rather than sea, no warehousing between arrival and your door, and cold packs in the box are what keep a peptide worth what you paid for it. We wrote about this in more detail in storing peptides in Egypt’s climate and how to verify peptide authenticity.
Availability in Egypt
We supply Retatrutide across the full range of vial sizes, priced in Egyptian pounds, sourced through authorized channels in Europe and the United States, and delivered by cold chain to every governorate within 3 to 5 days — free in Cairo and Giza. The rest of the metabolic range is in the fat loss collection.
This article is informational and is not medical advice. Not intended to diagnose, treat, cure or prevent any disease.